(Q68926213)
Statements
The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group (English)
R W Evans
B Rader
1 February 1990
scientific article published on 01 February 1990